Patents by Inventor Wei-Guo Su

Wei-Guo Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidinone compounds and uses thereof
    Patent number: 12630554
    Abstract: The present invention relates to pyrimidinone compounds and uses thereof. In particular, the present invention relates to pyrimidinone compounds of formula (I), pharmaceutical compositions comprising same, methods for preparing same, and uses thereof, wherein the variables are as defined in the description.
    Type: Grant
    Filed: August 17, 2021
    Date of Patent: May 19, 2026
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Weihan Zhang, Wei Deng, Haibin Yang
  • Anti-OX40 antibody and method of treatment
    Patent number: 12617861
    Abstract: Provided are an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method thereof and the use for treating OX40-related diseases or conditions.
    Type: Grant
    Filed: April 16, 2021
    Date of Patent: May 5, 2026
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Yizhen Yang, Yu Cai, Xiong Li, Lei Zhou, Weiguo Qing, Wei-Guo Su
  • TRIAZINE COMPOUNDS AND USES THEREOF
    Publication number: 20260055108
    Abstract: Provided are a triazine compound of formula (I), a pharmaceutical composition comprising same, a preparation method therefor and the use thereof.
    Type: Application
    Filed: September 1, 2023
    Publication date: February 26, 2026
    Inventors: Weihan ZHANG, Haibin YANG, Huaqing CAI, Wei-Guo SU
  • NOVEL PI3K AND/OR PIKK INHIBITORS, ANTIBODY-DRUG CONJUGATES COMPRISING THE SAME AND USES THEREOF
    Publication number: 20260048138
    Abstract: The present invention relates to the field of biopharmaceuticals, in particular to novel PI3K and/or PIKK inhibitors, antibody-drug conjugates (ADCs) comprising the same, methods of preparing the same, and uses thereof.
    Type: Application
    Filed: October 30, 2025
    Publication date: February 19, 2026
    Inventors: Weihan ZHANG, Haibin YANG, Wei-Guo SU
  • Tricyclic compounds and their use
    Patent number: 12492210
    Abstract: Tricyclic compounds and their use are provided. More specifically, tricyclic compounds, pharmaceutical compositions containing them, methods for preparing them, and their use in therapy are also provided.
    Type: Grant
    Filed: June 5, 2020
    Date of Patent: December 9, 2025
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Weihan Zhang, Jinshui Li
  • AMIDE COMPOUNDS AND USES THEREOF
    Publication number: 20250361223
    Abstract: Provided herein are novel amide compounds of formula (I), pharmaceutical compositions comprising same, methods for preparing same, and uses thereof, wherein the definition of each symbol is as described in the description.
    Type: Application
    Filed: August 12, 2025
    Publication date: November 27, 2025
    Inventors: Wei-Guo SU, Weihan ZHANG, Haibin YANG
  • Amide compounds and uses thereof
    Patent number: 12435062
    Abstract: The present invention relates to novel amide compounds of formula (I), pharmaceutical compositions comprising same, methods for preparing same, and uses thereof, wherein the definition of each symbol is as described in the description.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: October 7, 2025
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Weihan Zhang, Haibin Yang
  • CYCLOOLEFIN SUBSTITUTED HETEROAROMATIC COMPOUNDS AND THEIR USE
    Publication number: 20250223267
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable salt thereof, and/or solvates racemic mixtures, enantiomers, diasteromers, and tautomers thereof, wherein A, R1, R2, R3, R3?, R4, R4?, R5, R6, R7, R8, m, and n are as defined in the detailed description.
    Type: Application
    Filed: February 11, 2025
    Publication date: July 10, 2025
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo SU, Guangxiu DAI, Kun XIAO
  • Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor
    Publication number: 20250099462
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Application
    Filed: May 28, 2024
    Publication date: March 27, 2025
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • Cycloolefin substituted heteroaromatic compounds and their use
    Patent number: 12234211
    Abstract: Compounds of formula (I) or a pharmaceutically acceptable salt thereof, and/or solvates racemic mixtures, enantiomers, diasteromers, and tautomers thereof, wherein A, R1, R2, R3, R3?, R4, R4?, R5, R6, R7, R8, m, and n are as defined in the detailed description.
    Type: Grant
    Filed: May 18, 2022
    Date of Patent: February 25, 2025
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo Su, Guangxiu Dai, Kun Xiao
  • ANTI-OX40 ANTIBODY AND USES THEREOF
    Publication number: 20240301077
    Abstract: The present invention provides an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method therefor and the use for treating OX40-related diseases or conditions.
    Type: Application
    Filed: May 22, 2024
    Publication date: September 12, 2024
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Yizhen YANG, Yu CAI, Xiong LI, Lei ZHOU, Weiguo QING, Wei-Guo SU
  • Anti-OX40 antibody and uses thereof
    Patent number: 12030951
    Abstract: The present invention provides an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method therefor and the use for treating OX40-related diseases or conditions.
    Type: Grant
    Filed: August 18, 2022
    Date of Patent: July 9, 2024
    Assignee: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Yizhen Yang, Yu Cai, Xiong Li, Lei Zhou, Weiguo Qing, Wei-Guo Su
  • Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor
    Publication number: 20240139182
    Abstract: Provided are certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor.
    Type: Application
    Filed: December 13, 2023
    Publication date: May 2, 2024
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • HETEROAROMATIC COMPOUNDS AND USES THEREOF
    Publication number: 20240092774
    Abstract: Providing heteraromatic compounds and uses thereof. In particular, providing heteraromatic compounds of formula (I), pharmaceutical compositions comprising same, methods for preparing same and uses thereof, wherein the variables are as defined in the description.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 21, 2024
    Applicant: HUTCHISON MEDIPHARMA LIMITED
    Inventors: Wei-Guo SU, Weihan ZHANG, Haibin YANG
  • Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor
    Patent number: 11896592
    Abstract: Provided are certain triazolopyridines and triazolopyrazines of Formula 1, wherein X, Y, R1, R2, R3, R4 and R5 have any of the meanings described herein; processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: February 3, 2021
    Date of Patent: February 13, 2024
    Assignee: Hutchison Medipharma Limited
    Inventors: Wei-Guo Su, Hong Jia, Guangxiu Dai
  • PYRIMIDINONE COMPOUNDS AND USES THEREOF
    Publication number: 20240002388
    Abstract: It relates to pyrimidinone compounds and uses thereof. In particular, it relates to pyrimidinone compounds of formula (I), and the pharmaceutical compositions, the preparing methods and the uses thereof, wherein the variables are as defined in the description.
    Type: Application
    Filed: August 17, 2021
    Publication date: January 4, 2024
    Inventors: Wei-Guo SU, Weihan ZHANG, Wei DENG, Haibin YANG
  • ANTI-OX40 ANTIBODY AND USES THEREOF
    Publication number: 20230242657
    Abstract: Provided are an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method thereof and the use for treating OX40-related diseases or conditions.
    Type: Application
    Filed: April 16, 2021
    Publication date: August 3, 2023
    Inventors: Yizhen YANG, Yu CAI, Xiong LI, Lei ZHOU, Weiguo QING, Wei-Guo SU
  • AMIDE COMPOUNDS AND USES THEREOF
    Publication number: 20230174513
    Abstract: The present invention relates to novel amide compounds of formula (I), pharmaceutical compositions comprising same, methods for preparing same, and uses thereof, wherein the definition of each symbol is as described in the description.
    Type: Application
    Filed: March 29, 2021
    Publication date: June 8, 2023
    Inventors: Wei-Guo SU, Weihan ZHANG, Haibin YANG
  • ANTI-OX40 ANTIBODY AND USES THEREOF
    Publication number: 20230151105
    Abstract: The present invention provides an anti-OX40 antibody or antigen-binding fragment thereof, a preparation method therefor and the use for treating OX40-related diseases or conditions.
    Type: Application
    Filed: August 18, 2022
    Publication date: May 18, 2023
    Inventors: Yizhen YANG, Yu CAI, Xiong LI, Lei ZHOU, Weiguo QING, Wei-Guo SU
  • ANTI-CD47 ANTIBODY AND USES THEREOF
    Publication number: 20230151110
    Abstract: The present invention provides an anti-CD47 antibody or antigen-binding fragment thereof, a preparation method therefor and the use for treating or preventing CD47-related diseases.
    Type: Application
    Filed: April 11, 2021
    Publication date: May 18, 2023
    Inventors: Yu CAI, Yizhen YANG, Xiong LI, Xianwen YANG, Yongxin REN, Wei-Guo SU